Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study

Circulating Tumor Cells in Patients With Colorectal Liver Metastasis Predict Impaired Survival

(2015) Lars Thomas Seeberg et al.   ANNALS OF SURGERY

Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy

(2014) Nuh N Rahbari et al.   BMC CANCER

Immune Escape and Survival Mechanisms in Circulating Tumor Cells of Colorectal Cancer

(2014) Gunnar Steinert et al.   CANCER RESEARCH

Circulating tumor cells in colorectal cancer patients

(2013) Francesco Torino et al.   CANCER TREATMENT REVIEWS

Reduced Risk of Colorectal Cancer Up to 10 Years After Screening, Surveillance, or Diagnostic Colonoscopy

(2013) Hermann Brenner et al.   GASTROENTEROLOGY

Compartmental Differences of Circulating Tumor Cells in Colorectal Cancer

(2012) Nuh N. Rahbari et al.   ANNALS OF SURGICAL ONCOLOGY

Circulating tumour cells in non-metastatic breast cancer: a prospective study

(2012) Anthony Lucci et al.   LANCET ONCOLOGY

Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

(2012) J. Sastre et al.   ONCOLOGIST

Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse

(2011) C-Y Lu et al.   BRITISH JOURNAL OF CANCER

The clinical significance of circulating tumor cells in non-metastatic colorectal cancer – A review

(2011) M. Thorsteinsson et al.   EJSO

Clinical Significance of Circulating Tumor Cells, Including Cancer Stem-Like Cells, in Peripheral Blood for Recurrence and Prognosis in Patients With Dukes' Stage B and C Colorectal Cancer

(2011) Hisae Iinuma et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features

(2011) Erin S. O'Connor et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Detection of Tumor Cells in Regional Lymph Nodes Is Associated With Disease Recurrence and Poor Survival in Node-Negative Colorectal Cancer: A Systematic Review and Meta-Analysis

(2011) Nuh N. Rahbari et al.   JOURNAL OF CLINICAL ONCOLOGY

Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up

(2010) R. Labianca et al.   ANNALS OF ONCOLOGY

Meta-analysis Shows That Detection of Circulating Tumor Cells Indicates Poor Prognosis in Patients With Colorectal Cancer

(2010) Nuh N. Rahbari et al.   GASTROENTEROLOGY

Colorectal cancer

(2010) David Cunningham et al.   LANCET

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer

(2009) S. J. Cohen et al.   ANNALS OF ONCOLOGY

Validation of Prognostic Scoring Systems for Patients Undergoing Resection of Colorectal Cancer Liver Metastases

(2009) Christoph Reissfelder et al.   ANNALS OF SURGICAL ONCOLOGY

Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients

(2009) S. C. C. Wong et al.   CLINICAL CANCER RESEARCH

Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer

(2009) M. Craig Miller et al.   Journal of Oncology

Persistent Presence of Postoperative Circulating Tumor Cells is a Poor Prognostic Factor for Patients with Stage I–III Colorectal Cancer after Curative Resection

(2008) Yih-Huei Uen et al.   ANNALS OF SURGICAL ONCOLOGY

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

(2008) Steven J. Cohen et al.   JOURNAL OF CLINICAL ONCOLOGY